Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells
Józefa Węsierska-Gądek, David Gritsch, Nora Zulehner, Oxana Komina, Margarita MaurerVolume:
112
Year:
2011
Language:
english
Pages:
12
DOI:
10.1002/jcb.23004
File:
PDF, 379 KB
english, 2011